WRF
PFE icon

Waddell & Reed Financial’s Pfizer PFE Stock Holding History

Waddell & Reed Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,349,626
Closed -$41.8M – 482
2020
Q1 		$41.8M Buy
1,349,626
+29,747
+2% +$1.01M 0.14% 180
2019
Q4 		$49.1M Sell
1,319,879
-2,076,360
-61% -$74M 0.12% 200
2019
Q3 		$116M Sell
3,396,239
-3,762,143
-53% -$137M 0.3% 96
2019
Q2 		$294M Sell
7,158,382
-1,961,188
-22% -$77.9M 0.73% 26
2019
Q1 		$367M Sell
9,119,570
-620,675
-6% -$24.9M 0.91% 22
2018
Q4 		$403M Sell
9,740,245
-492,066
-5% -$20.4M 1.14% 10
2018
Q3 		$428M Buy
10,232,311
+4,245,265
+71% +$163M 0.95% 17
2018
Q2 		$206M Sell
5,987,046
-144,402
-2% -$4.93M 0.48% 49
2018
Q1 		$206M Sell
6,131,448
-881,165
-13% -$30.3M 0.47% 54
2017
Q4 		$241M Sell
7,012,613
-212,845
-3% -$7.26M 0.53% 46
2017
Q3 		$245M Buy
7,225,458
+295,095
+4% +$9.48M 0.54% 47
2017
Q2 		$221M Buy
6,930,363
+460,152
+7% +$14.5M 0.49% 53
2017
Q1 		$210M Sell
6,470,211
-21,212
-0.3% -$669K 0.45% 65
2016
Q4 		$200M Sell
6,491,423
-851,319
-12% -$26M 0.44% 61
2016
Q3 		$236M Sell
7,342,742
-580,757
-7% -$19.4M 0.49% 54
2016
Q2 		$265M Sell
7,923,499
-2,432,680
-23% -$77.6M 0.56% 51
2016
Q1 		$291M Sell
10,356,179
-3,998,863
-28% -$114M 0.55% 61
2015
Q4 		$440M Sell
14,355,042
-1,888,898
-12% -$59.4M 0.71% 35
2015
Q3 		$484M Buy
16,243,940
+14,405,828
+784% +$462M 0.8% 34
2015
Q2 		$58.5M Buy
1,838,112
+249,271
+16% +$8.12M 0.08% 209
2015
Q1 		$52.4M Buy
1,588,841
+203,423
+15% +$6.47M 0.07% 223
2014
Q4 		$40.9M Buy
1,385,418
+100,570
+8% +$2.88M 0.06% 249
2014
Q3 		$36M Sell
1,284,848
-375,176
-23% -$10.5M 0.05% 259
2014
Q2 		$46.7M Sell
1,660,024
-18,886,514
-92% -$538M 0.07% 245
2014
Q1 		$626M Sell
20,546,538
-885,808
-4% -$26.4M 0.95% 25
2013
Q4 		$623M Sell
21,432,346
-301,711
-1% -$8.78M 1% 20
2013
Q3 		$592M Buy
21,734,057
+170,780
+0.8% +$4.65M 1.13% 15
2013
Q2 		$573M Buy
+21,563,277
New +$596M 1.2% 16

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Waddell & Reed Financial's PFE Position: Q2 2020 in Review

Waddell & Reed Financial sold out of Pfizer (PFE) in Q2 2020, closing a stake of 1,349,626 shares — an estimated $41.8M sold.

Waddell & Reed Financial first reported a position in PFE in Q2 2013 and held it in 28 quarters. The position peaked at $626M in Q1 2014. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Waddell & Reed Financial reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
  • Waddell & Reed Financial sold 1,349,626 Pfizer shares in Q2 2020, an estimated $41.8M.
  • Waddell & Reed Financial first reported a position in Pfizer in Q2 2013 and held it in 28 quarters.
  • Waddell & Reed Financial's Pfizer position peaked at $626M in Q1 2014.
  • 2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Waddell & Reed Financial's 13F filing for Q2 2020, filed 14 Aug 2020.